Return to homepagePandemic Pact

DEVELOPMENT OF AN ANTIVIRAL FOR YELLOW FEVER VIRUS INFECTION

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N93023C00003-0-9999-1

Grant search

Key facts

  • Disease

    Yellow Fever, Disease X

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $5,493,876

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    JINHONG CHANG

  • Research Location

    United States of America

  • Lead Research Institution

    BARUCH S. BLUMBERG INSTITUTE

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

To support the advanced development of a promising candidate therapeutic for a virus covered under the Antiviral Program for Pandemics. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.